Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.98
-0.82 (-9.32%)
At close: Oct 13, 2026, 4:00 PM EDT
7.96
-0.02 (-0.25%)
After-hours: Oct 13, 2026, 7:53 PM EDT
Sagimet Biosciences Employees
Sagimet Biosciences had 16 employees as of December 31, 2025. The number of employees increased by 2 or 14.29% compared to the previous year. That makes Sagimet Biosciences the 38,964th largest employer in the world and 5,725th in the United States.
Employees
16
Change (1Y)
2
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$2,942,438
Market Cap
565.85M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 16 | 2 | 14.29% | 16 | 0 |
| Dec 31, 2024 | 14 | 4 | 40.00% | 14 | 0 |
| Dec 31, 2023 | 10 | 0 | - | 8 | 2 |
| Dec 31, 2022 | 10 | 3 | 42.86% | 9 | 1 |
| Dec 31, 2020 | 7 | - | - | 6 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Wave Life Sciences | 317 |
| CorMedix | 191 |
| Olema Pharmaceuticals | 150 |
| Prime Medicine | 146 |
| Crescent Biopharma | 69 |
| Shattuck Labs | 40 |
| Climb Bio | 29 |
| Faeth Therapeutics | 29 |
SGMT News
- 4 days ago - Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference - GlobeNewsWire
- 11 days ago - Sagimet Biosciences price target raised to $26 from $25 at Guggenheim - TheFly
- 12 days ago - Sagimet Biosciences Announces Closing of Underwritten Offering of Series A Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 12 days ago - Sagimet Biosciences price target raised to $38 from $33 at Oppenheimer - TheFly
- 12 days ago - Sagimet Biosciences price target lowered to $27 from $29 at Citizens - TheFly
- 13 days ago - Sagimet Biosciences’ China data strengthens denifanstat case, says Clear Street - TheFly
- 13 days ago - Sagimet Biosciences Transcript: KOL event - Transcripts
- 13 days ago - Sagimet Biosciences Press release: KOL event - Filings